Detalles de la búsqueda
1.
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.
Gynecol Oncol
; 161(2): 502-507, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612336
2.
Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes.
Transl Oncol
; 15(1): 101256, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717279
3.
Cervical cancer subtypes harbouring integrated and/or episomal HPV16 portray distinct molecular phenotypes based on transcriptome profiling of mRNAs and miRNAs.
Cell Death Discov
; 5: 81, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30937183
4.
Expression signatures of HOX cluster genes in cervical cancer pathogenesis: Impact of human papillomavirus type 16 oncoprotein E7.
Oncotarget
; 8(22): 36591-36602, 2017 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28402266
5.
Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions.
PLoS One
; 7(9): e44678, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22970286
Resultados
1 -
5
de 5
1
Próxima >
>>